During the past decade, Pahang Buddhist Association conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pahang Buddhist Association" are "Anaemia" (1 trials), "Chronic Kidney Disease" (1 trials), "Chronic Renal Failure Related Anemia" (1 trials) and "End-Stage Renal Failure" (1 trials). Many other conditions were trialed in "Pahang Buddhist Association" in a lesser frequency.

Most popular intervention types in "Pahang Buddhist Association" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Biogeneric Epoetin" (1 trials) and "GerEPO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pahang Buddhist Association" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pahang Buddhist Association". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Pahang Buddhist Association, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pahang Buddhist Association, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".